The Role of SIRT1 in Leukemia

Curr Treat Options Oncol. 2024 Oct;25(10):1283-1288. doi: 10.1007/s11864-024-01265-6. Epub 2024 Oct 2.

Abstract

Leukemia is a type of hematological malignancy (HM) caused by uncontrolled proliferation, apoptosis, and differentiation of hematopoietic stem cells (HSCs). Leukemia cells proliferate greatly in the bone marrow (BM), infiltrate other tissues and organs, and affect the normal hematopoietic function. Although the emergence of new targeted agents and immune agents has improved the prognosis of patients, due to the complex pathogenic factors and heterogeneity of leukemia, there are still some patients with poor prognosis. Recent studies have shown that silent information regulator 1 (SIRT1) is involved in the proliferation, apoptosis, metabolism, and senescence of leukemia cells. As a double-edged sword in leukemia cells, SIRT1 can both promote and inhibit the growth of leukemia cells. Since its mechanism of action has not been elucidated, it is urgent to explore the regulatory mechanism of SIRT1 in leukemia. In this review, we discussed the mechanisms of SIRT1 in different aspects of leukemia, providing a theoretical basis for the treatment of patients with leukemia.

Keywords: Autophagy; DNA damage repair; Leukemia; SIRT1.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Cell Proliferation
  • Disease Management
  • Disease Susceptibility
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Leukemia* / etiology
  • Leukemia* / metabolism
  • Leukemia* / pathology
  • Leukemia* / therapy
  • Prognosis
  • Signal Transduction
  • Sirtuin 1* / metabolism

Substances

  • Sirtuin 1
  • SIRT1 protein, human